Submit your abstract

Young Investigators Scientific Session

A parallel scientific session dedicated to Young Investigators will once more be included in the scientific programme of the ISBT Congress. 

If you would like your abstract to be considered for oral presentation in this session, you can indicate this during the abstract submission process.

The Young Investigator Scientific Session will take place on Monday June 4, 14:00 - 15:30 hrs.

You should be undertaking research in a topic related to transfusion medicine and you must meet the following requirements:

  • Be 35 years of age or under (proof of age will be required if successful)
  • Working towards a PhD
  • Working towards a Masters degree
  • Undertaking high level research

Harold Gunson Travel Grant

All Young Investigators who are 40 years or younger could apply for the Harold Gunson Fellowship when submitting an abstract.

All successful applicants will receive complimentary registration to the congress. Flight and accommodation costs are covered by ISBT.

Closing date for applications is Thursday February 22.

Before you send your application please make sure that you have read the Harold Gunson Fellowship Procedure carefully and that you:

  • Are 40 years or younger at the date of the first day of the congress
  • You are the first, submitting and presenting author of an abstract which has been accepted for the scientific programme

Please note that successful applicants from very high and high HDI countries may only receive the award once and from medium and low HDI countries twice. To find out in which category your country is in, click here.




Abstract Book

Electronic versions of the abstracts can be downloaded on the ISBT Congress website, on the mobile application and on the Wiley website two weeks prior to the congress. 

The Science Series will only be available on the Wiley website and can be downloaded after the congress. 

Neither the abstracts nor the Science Series will be available as hard-copies.


1.1 Organisational issues
1.2 Information technology
1.3 Cost/effectiveness
1.4 Training and education
1.5 Risk models, standards and regulation
1.6 Blood supply management and utilization
1.7 Quality management

2.1 Blood donor recruitment
2.2 Blood collection including apheresis
2.3 Donor adverse events

3.1 Blood processing, storage and release
3.2 Blood components
3.3 Plasma products
3.4 Pathogen inactivation
3.5 Novel blood products

4.1 Screening strategies for TTI
4.2 Hepatitis B (HBV)
4.3 Hepatitis C (HCV)
4.4 HIV
4.5 Bacteria
4.6 Parasites
4.7 Newly emerging pathogens and other transfusion related pathogens

5.1 Red cell immunology: Serology
5.2 Red cell immunology: Molecular
5.3 Platelet immunology
5.4 Granulocyte immunology
5.5 Fetal-maternal immunology

6.1 Neonatal and pediatric transfusion
6.2 Therapeutic apheresis
6.3 Evidence based transfusion medicine practice
6.4 Haemorrhage and massive transfusion
6.5 Adverse events, including TRALI
6.6 Haemovigilance and transfusion safety
6.7 Alternatives to blood transfusion
6.8 Transfusion practitioner related clinical practice improvement

7.1 Stem cell and tissue banking, including cord blood
7.2 Collection, processing, storage and release
7.3 Clinical applications

8.1 HLA in transfusion medicine
8.2 Histocompatibility in stem cell transplantation
8.3 Histocompatibility in organ transplantation



"I am happy to receive Vox Sanguinis"

Birgit Lund, Denmark
Become a member from 55,- euro p/y Join us now